[{"address1": "3 Sugar Creek Center Boulevard", "address2": "Suite 525", "city": "Sugar Land", "state": "TX", "zip": "77478", "country": "United States", "phone": "713 489 8654", "website": "https://tvarditherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in pre-clinical stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Dr. Imran  Alibhai Ph.D.", "age": 49, "title": "CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 857330, "exercisedValue": 0, "unexercisedValue": 5634519}, {"maxAge": 1, "name": "Mr. Wallace  Hall", "age": 63, "title": "Founder, President & Director", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dan  Conn J.D., M.B.A.", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 552595, "exercisedValue": 0, "unexercisedValue": 886998}, {"maxAge": 1, "name": "Dr. John  Kauh M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 565830, "exercisedValue": 0, "unexercisedValue": 434300}, {"maxAge": 1, "name": "Mr. David J. Tweardy M.D.", "title": "Co-Founder & Scientific Advisory Board Member", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronald A. DePinho M.D.", "age": 70, "title": "Co-Founder & Chairman of Scientific Advisory Board", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael T. Lewis Ph.D.", "title": "Co-Founder & Scientific Advisory Board Member", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey  Larson DABT, Ph.D.", "age": 63, "title": "Senior Vice President of R&D", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  O'Brien CPA", "title": "VP of Finance & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yixin  Chen Ph.D.", "age": 64, "title": "Vice President of CMC", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.51, "open": 4.51, "dayLow": 4.5, "dayHigh": 4.66, "regularMarketPreviousClose": 4.51, "regularMarketOpen": 4.51, "regularMarketDayLow": 4.5, "regularMarketDayHigh": 4.66, "payoutRatio": 0.0, "forwardPE": -2.1617787, "volume": 23387, "regularMarketVolume": 23387, "averageVolume": 174785, "averageVolume10days": 114200, "averageDailyVolume10Day": 114200, "bid": 4.46, "ask": 4.7, "bidSize": 1, "askSize": 1, "marketCap": 42872744, "fiftyTwoWeekLow": 3.74, "fiftyTwoWeekHigh": 43.65, "allTimeHigh": 1067.292, "allTimeLow": 3.74, "fiftyDayAverage": 4.149, "twoHundredDayAverage": 19.472244, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6640742, "profitMargins": 0.0, "floatShares": 6261484, "sharesOutstanding": 9381344, "sharesShort": 632646, "sharesShortPriorMonth": 925143, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0674, "heldPercentInsiders": 0.36793, "heldPercentInstitutions": 0.28104, "shortRatio": 4.62, "impliedSharesOutstanding": 9381344, "bookValue": 2.971, "priceToBook": 1.5382028, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -23646000, "trailingEps": -2.25, "forwardEps": -2.114, "lastSplitFactor": "1:3", "lastSplitDate": 1744761600, "enterpriseToEbitda": -0.222, "52WeekChange": -0.6688406, "SandP52WeekChange": 0.14725316, "quoteType": "EQUITY", "currentPrice": 4.57, "targetHighPrice": 15.0, "targetLowPrice": 4.0, "targetMeanPrice": 8.66667, "targetMedianPrice": 8.0, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 36460000, "totalCashPerShare": 3.886, "ebitda": -29868000, "totalDebt": 228000, "quickRatio": 3.303, "currentRatio": 3.482, "debtToEquity": 0.818, "returnOnAssets": -0.72676, "returnOnEquity": -1.3563901, "freeCashflow": -12512875, "operatingCashflow": -22647000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TVRD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tvardi Therapeutics, Inc.", "longName": "Tvardi Therapeutics, Inc.", "regularMarketChangePercent": 1.33038, "regularMarketPrice": 4.57, "exchange": "NCM", "messageBoardId": "finmb_570288312", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.25, "epsForward": -2.114, "epsCurrentYear": -1.836, "priceEpsCurrentYear": -2.489107, "fiftyDayAverageChange": 0.421, "fiftyDayAverageChangePercent": 0.10147023, "twoHundredDayAverageChange": -14.902245, "twoHundredDayAverageChangePercent": -0.765307, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1391178600000, "postMarketChangePercent": 0.0, "postMarketPrice": 4.57, "postMarketChange": 0.0, "regularMarketChange": 0.0599999, "regularMarketDayRange": "4.5 - 4.66", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 174785, "fiftyTwoWeekLowChange": 0.83000016, "fiftyTwoWeekLowChangePercent": 0.22192517, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1768597804, "regularMarketTime": 1768597201, "fiftyTwoWeekRange": "3.74 - 43.65", "fiftyTwoWeekHighChange": -39.08, "fiftyTwoWeekHighChangePercent": -0.89530355, "fiftyTwoWeekChangePercent": -66.884056, "earningsTimestamp": 1763067600, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "displayName": "Tvardi Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]